Lexicon Pharmaceuticals, Inc.
USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS

Last updated:

Abstract:

The invention relates to the use of sotagliflozin to improve glycemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI).gtoreq.27 kg/m.sup.2.

Status:
Application
Type:

Utility

Filling date:

28 Feb 2020

Issue date:

11 Feb 2021